Previous 10 | Next 10 |
SAN DIEGO , July 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today that it will be conducting a conference call to discuss...
DelMar Pharmaceuticals ( DMPI +1.3% ) received a $500K loan from the National Brain Tumor Society and the National Foundation for Cancer Research in order to support VAL-083's preparation for participation in a sponsored trial and study. More news on: DelMar Pharmaceuticals, Inc.,...
SAN DIEGO , June 24, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today it has received a $500,000 loan from the Nationa...
Nano cap DelMar Pharmaceuticals ( DMPI -16.5% ) slumps on more than triple normal volume on the heels of updated data from an open-label Phase 2 clinical trial evaluating VAL-083 (dianhydrogalactitol) in newly diagnosed patients with MGMT-unmethylated glioblastoma multiforme (GBM). Mor...
SAN DIEGO , June 22, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced positive interim data from its two Phase 2 tria...
Chembio Diagnostics (NASDAQ: CEMI ) -60% after FDA yanks emergency use authorization of COVID-19 blood test. More news on: Chembio Diagnostics, Inc., BioCardia, Inc., Beasley Broadcast Group, Inc., Stocks on the move, , Read more ...
Do You Have These 2 Pharmaceutical Stocks On Your 2020 Watchlist? Pharmaceutical stocks tend to create more momentum when news about developing new medicine or financials about a company are released. Currently, we’re dealing with an economic crisis. However, that does not necessarily...
DelMar Pharmaceuticals (NASDAQ: DMPI ) enters into a definitive merger agreement with privately-held Adgero Biopharmaceuticals, under which it will acquire Adgero in an all-equity transaction. More news on: DelMar Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
SAN DIEGO & PRINCETON, N.J. , June 10, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar") and Adgero Biopharmaceuticals Holdings, Inc. ("Adgero") today announced the companies have entered into a definitive merger agreement pursuant to ...
SAN DIEGO , June 4, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced today the acceptance of an invitation from the Global Coaliti...
News, Short Squeeze, Breakout and More Instantly...
DelMar Pharmaceuticals Company Name:
DMPI Stock Symbol:
NASDAQ Market:
SAN DIEGO , Aug. 18, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that it has entered into definitive agreements with investors providing for the sale and issuance of up to 19,587 shares of its Series C Convert...
SAN DIEGO , Aug. 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that all proposals related to the proposed merger between DelMar and Adgero were approved by DelMar's stockholders at a special meeting held on August 14...
SAN DIEGO , July 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today that it will be conducting a conference call to discuss...